Format

Send to

Choose Destination
EBioMedicine. 2016 Jan 18;4:95-103. doi: 10.1016/j.ebiom.2016.01.020. eCollection 2016 Feb.

Bacterial Cytological Profiling (BCP) as a Rapid and Accurate Antimicrobial Susceptibility Testing Method for Staphylococcus aureus.

Author information

1
Department of Bioengineering, University of California, San Diego La Jolla, CA, USA; Division of Biological Sciences, University of California, San Diego La Jolla, CA, USA.
2
Division of Pediatric Pharmacology & Drug Discovery, University of California, San Diego La Jolla, CA, USA.
3
Division of Pediatric Pharmacology & Drug Discovery, University of California, San Diego La Jolla, CA, USA; Skaggs School of Pharmacy and Pharmaceutical Science, University of California, San Diego La Jolla, CA, USA.
4
Division of Biological Sciences, University of California, San Diego La Jolla, CA, USA.

Abstract

Successful treatment of bacterial infections requires the timely administration of appropriate antimicrobial therapy. The failure to initiate the correct therapy in a timely fashion results in poor clinical outcomes, longer hospital stays, and higher medical costs. Current approaches to antibiotic susceptibility testing of cultured pathogens have key limitations ranging from long run times to dependence on prior knowledge of genetic mechanisms of resistance. We have developed a rapid antimicrobial susceptibility assay for Staphylococcus aureus based on bacterial cytological profiling (BCP), which uses quantitative fluorescence microscopy to measure antibiotic induced changes in cellular architecture. BCP discriminated between methicillin-susceptible (MSSA) and -resistant (MRSA) clinical isolates of S. aureus (n = 71) within 1-2 h with 100% accuracy. Similarly, BCP correctly distinguished daptomycin susceptible (DS) from daptomycin non-susceptible (DNS) S. aureus strains (n = 20) within 30 min. Among MRSA isolates, BCP further identified two classes of strains that differ in their susceptibility to specific combinations of beta-lactam antibiotics. BCP provides a rapid and flexible alternative to gene-based susceptibility testing methods for S. aureus, and should be readily adaptable to different antibiotics and bacterial species as new mechanisms of resistance or multidrug-resistant pathogens evolve and appear in mainstream clinical practice.

KEYWORDS:

Antibiotic resistance; Multidrug resistant bacteria; Staphylococcus aureus; Susceptibility tests

PMID:
26981574
PMCID:
PMC4776060
DOI:
10.1016/j.ebiom.2016.01.020
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center